Less familiar and understudied is hemoglobin SC, or HbSC, the second most common type, which affects about 25% of those with sickle cell disease. Clinicians have long regarded HbSC as a "mild" type of ...

Sickle cell disease causes premature aging of blood stem cells, which scientists may be able to address with a special class ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...

CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to prevent pain crises by reducing the neutrophil levels in the blood: Researchers ...

Avascular necrosis is the breakdown and death of bone tissue due to insufficient blood supply. It’s a common complication of sickle cell disease, but early diagnosis and treatment can help slow ...

A New Orleans man became the first person in Louisiana cured of sickle cell disease through gene therapy, drawing attention ...

Add Yahoo as a preferred source to see more of our stories on Google. Two scientists whose work ushered in the first approved therapy using the gene-editing tool CRISPR have won the $3 million ...